
China and its proxies have been observed attempting to identify and illicitly obtain valuable intellectual property and public health data related to vaccines, treatments and testing from networks and personnel affiliated with COVID-19-related research, which could jeopardize the delivery of secure, effective and efficient treatment options, the FBI and CISA warned.